2-chloro-N-cyclopropyl-5-methylpyrimidin-4-amine | 1050602-57-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2-chloro-N-cyclopropyl-5-methylpyrimidin-4-amine
• CAS: 1050602-57-7
• 化学式: C₈H₁₀ClN₃
• 分子量: 183.64
• InChiKey: XRLBKEJGNCLKSD-UHFFFAOYSA-N

物化性质

• 沸点：
  368.5±22.0 °C(Predicted)
• 密度：
  1.382±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  37.8
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSÉS CHIMIQUES
  申请人：BORAGEN INC

  公开号：WO2021003501A1

  公开（公告）日：2021-01-07

  The present disclosure describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. Compounds of the disclosure have activity as dual modulators of Janus kinase (JAK), alone, or in combination with one or more of an additional mechanism, including a tyrosine kinase, such as TrkA or Syk, and PDE4, and are useful in the in the treatment or control of inflammation, auto-immune diseases, cancer, and other disorders and indications where modulation of JAK would be desirable. Also described herein are methods of treating inflammation, auto-immune diseases, cancer, and other conditions susceptible to inhibition of JAK and PDE4 by administering a compound herein described.

  本公开描述了新颖的化合物，或其药用可接受的盐，含有它们的药物组合物，以及它们的医疗用途。本公开的化合物具有作为Janus激酶（JAK）的双重调节剂的作用，单独使用，或与一个或多个附加机制（包括酪氨酸激酶，如TrkA或Syk，以及PDE4）结合使用，并且在治疗或控制炎症、自身免疫疾病、癌症以及其他调节JAK会可取的失调和其他适应症中是有用的。此外，还描述了通过施用本处所述的化合物来治疗炎症、自身免疫疾病、癌症以及其他易受JAK和PDE4抑制的状况的方法。
• Heterocyclically Substituted Anilinopyrimidines
  申请人：Wasnaire Pierre

  公开号：US20110245249A1

  公开（公告）日：2011-10-06

  Heterocyclically substituted anilinopyrimidines of the formula (I) in which R 1 to R 12 and E1, E2, E3, L 1 , Y, Z and L 2 have the meanings given in the description, and agrochemically active salts thereof, their use and also methods and compositions for controlling phytopathogenic harmful fungi in and/or on plants or in and/or on seed of plants, processes for preparing such compositions and treated seed and also their use for controlling phytopathogenic harmful fungi in agriculture, horticulture and forestry, in the protection of materials and in the domestic and hygiene field. The present invention furthermore relates to a process for preparing heterocyclically substituted anilinopyrimidinenes of the formula (I).

  公式(I)中的杂环取代苯基嘧啶，其中R1至R12和E1、E2、E3、L1、Y、Z和L2具有描述中给出的含义，以及其农用活性盐，它们的用途以及控制植物或种子中和/或植物中和/或植物种子上的植物病原真菌的方法和组合物，用于制备这种组合物的过程以及受处理的种子，以及其在农业、园艺和林业中控制植物病原真菌的用途，在材料保护以及家庭和卫生领域。本发明还涉及制备公式(I)中的杂环取代苯基嘧啶的方法。
• DIAMINOPYRIMIDINES AS FUNGICIDES
  申请人：Greul Joerg Nico

  公开号：US20100081679A1

  公开（公告）日：2010-04-01

  Use of diaminopyrimidines of the formula (I) in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and X 1 , X 2 and A have the meanings given in the description, and also agrochemically active salts thereof as fungicides. Diaminopyrimidines of the formulae (Ia), (Ib), (Ic), (Id), (Ie), (If) in which R 8a , R 8b , R 8c , R 8d , R 8e , R 8f , R 3b , R 3c , R 3e , X 1b , X 1c , X 1e and R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and X 1 , X 2 and A have the meanings given in the description, and also agrochemically active salts thereof and their use for controlling unwanted microorganisms.

  使用公式(I)中的二氨基嘧啶，其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11和X1、X2和A具有描述中给出的含义，以及其作为杀菌剂的农药活性盐。公式(Ia)、(Ib)、(Ic)、(Id)、(Ie)、(If)中的二氨基嘧啶，其中R8a、R8b、R8c、R8d、R8e、R8f、R3b、R3c、R3e、X1b、X1c、X1e和R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11和X1、X2和A具有描述中给出的含义，以及其作为农药活性盐的使用以及用于控制不受欢迎的微生物。
• FLUORINE-18 AND CARBON-11 LABELED RADIOLIGANDS FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR LRRK2
  申请人：Genentech, Inc.

  公开号：US20130156700A1

  公开（公告）日：2013-06-20

  A method for positron emission tomography (PET) imaging of LRRK2 in tissue of a subject, the method comprising: administering a compound of formula I, formula II or formula III, or a pharmaceutically acceptable salt thereof to the subject, wherein the compound includes at least one C 11 or F 18 label thereon; allowing the compound to penetrate into the tissue of the subject; and collecting a PET image of the CNS or brain tissue of the subject

  一种用于在受试者组织中进行LRRK2正电子发射断层扫描（PET）成像的方法，包括：向受试者给予公式I、公式II或公式III的化合物或其药学上可接受的盐，其中该化合物上至少有一个C11或F18标记；使该化合物渗入受试者的组织中；并收集受试者的中枢神经系统或脑组织的PET图像。
• NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF
  申请人：FUJIFILM Corporation

  公开号：EP2840080B1

  公开（公告）日：2017-12-06